Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

• Status: Completed
• Trial end date: 2004-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Cetirizine; Levocetirizine; Loratadine

Criteria

Inclusion Criteria:

• Male or female, 18 to 60 years old (inclusive

• having chronic idiopathic urticaria

• at least 6-weeks history of CIU, had at least 3 days of wheals presence/week

• moderate to severe CIU defined as pruritus score ≥ 2, number of wheals ≥ 2, and total symptoms CIU score ≥ 2 at randomization

Exclusion Criteria:

• Asthma requiring daily drug therapy other than ß2 inhaled agonists taken prn

• atopic dermatitis or urticaria requiring an antihistamine treatment or the administration of oral or dermal topical corticosteroids

• urticaria caused by physical factors or other known factors

• cholinergic urticaria

• had urticaria due to other systemic disorders

• were on antihistamine drug currently